CVSI OTC
CV Sciences, Inc.
1W: -6.6%
1M: -33.9%
3M: -37.6%
YTD: -80.0%
1Y: -74.5%
3Y: -73.3%
5Y: -95.2%
$0.01
-0.00 (-5.41%)
Weekly Expected Move ±21.7%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2024-05-14
Earliest Filing
2024-11-21
Latest Filing
target: 3
supplier: 1
Counterparties (Filed by CVSI)
4 relationshipsCompanies named in CVSI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Extract Labs, Inc. | — | target | Target company acquired by CV Sciences, Inc. in a definitive Stock Purchase Agreement. | 2024-11-21 | View |
| Higher Love Wellness Company, LLC | — | target | Seller of Extract Labs shares in the acquisition transaction. | 2024-11-21 | View |
| 1399 Horizon LLC | — | supplier | Landlord leasing property to Extract Labs and indemnifying against loan liabilities. | 2024-11-21 | View |
| Elevated Softgels, LLC | — | target | CV Sciences, Inc. acquired all outstanding equity interests in this Delaware limited liability company, making it a whol | 2024-05-14 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-13 | Earnings Release; Other Events; Exhibits | View | |
| 2026-06-04 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-04-10 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-03-26 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-03-10 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-11-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-10-10 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-09-18 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-08-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-06-05 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-05-14 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-03-27 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-02-20 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-02-19 | Other Events | View | |
| 2025-02-11 | Termination of Material Definitive Agreement | View | |
| 2024-11-25 | Other Events | View | |
| 2024-11-21 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2024-11-14 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-08-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-07-09 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR